Cargando…
6. Asthma: Factors underlying inception, exacerbation, and disease progression
Asthma is a heterogeneous disorder that is characterized by variable airflow obstruction, airway inflammation and hyperresponsiveness, and reversibility either spontaneously or as a result of treatment. Multiple causes no doubt exist for both its inception and symptom exacerbation once the disease i...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119312/ https://www.ncbi.nlm.nih.gov/pubmed/16455346 http://dx.doi.org/10.1016/j.jaci.2005.07.006 |
_version_ | 1783514747245690880 |
---|---|
author | Lemanske, Robert F. Busse, William W. |
author_facet | Lemanske, Robert F. Busse, William W. |
author_sort | Lemanske, Robert F. |
collection | PubMed |
description | Asthma is a heterogeneous disorder that is characterized by variable airflow obstruction, airway inflammation and hyperresponsiveness, and reversibility either spontaneously or as a result of treatment. Multiple causes no doubt exist for both its inception and symptom exacerbation once the disease is established. Factors underlying inception can range from viral respiratory tract infections in infancy to occupational exposures in adults. Factors underlying asthma exacerbations include allergen exposure in sensitized individuals, viral infections, exercise, irritants, and ingestion of nonsteroidal anti-inflammatory agents among others. Exacerbating factors might include one or all of these exposures and vary both among and within patients. Asthma treatment is determined to a large extent after an assessment of severity, which can be variable over time and assessed in 2 domains: impairment (current) and risk (long-term consequences). Unfortunately, despite the availability of effective therapies, suboptimal asthma control exists in many patients on a worldwide basis. The future development of novel therapies and treatment paradigms should address these disparities. |
format | Online Article Text |
id | pubmed-7119312 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71193122020-04-08 6. Asthma: Factors underlying inception, exacerbation, and disease progression Lemanske, Robert F. Busse, William W. J Allergy Clin Immunol Article Asthma is a heterogeneous disorder that is characterized by variable airflow obstruction, airway inflammation and hyperresponsiveness, and reversibility either spontaneously or as a result of treatment. Multiple causes no doubt exist for both its inception and symptom exacerbation once the disease is established. Factors underlying inception can range from viral respiratory tract infections in infancy to occupational exposures in adults. Factors underlying asthma exacerbations include allergen exposure in sensitized individuals, viral infections, exercise, irritants, and ingestion of nonsteroidal anti-inflammatory agents among others. Exacerbating factors might include one or all of these exposures and vary both among and within patients. Asthma treatment is determined to a large extent after an assessment of severity, which can be variable over time and assessed in 2 domains: impairment (current) and risk (long-term consequences). Unfortunately, despite the availability of effective therapies, suboptimal asthma control exists in many patients on a worldwide basis. The future development of novel therapies and treatment paradigms should address these disparities. American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. 2006-02 2006-02-07 /pmc/articles/PMC7119312/ /pubmed/16455346 http://dx.doi.org/10.1016/j.jaci.2005.07.006 Text en Copyright © 2006 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Lemanske, Robert F. Busse, William W. 6. Asthma: Factors underlying inception, exacerbation, and disease progression |
title | 6. Asthma: Factors underlying inception, exacerbation, and disease progression |
title_full | 6. Asthma: Factors underlying inception, exacerbation, and disease progression |
title_fullStr | 6. Asthma: Factors underlying inception, exacerbation, and disease progression |
title_full_unstemmed | 6. Asthma: Factors underlying inception, exacerbation, and disease progression |
title_short | 6. Asthma: Factors underlying inception, exacerbation, and disease progression |
title_sort | 6. asthma: factors underlying inception, exacerbation, and disease progression |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119312/ https://www.ncbi.nlm.nih.gov/pubmed/16455346 http://dx.doi.org/10.1016/j.jaci.2005.07.006 |
work_keys_str_mv | AT lemanskerobertf 6asthmafactorsunderlyinginceptionexacerbationanddiseaseprogression AT bussewilliamw 6asthmafactorsunderlyinginceptionexacerbationanddiseaseprogression |